With the analysis among 269 patents, we discovered top 52 key players by total patent application. Etypharm, Allergan, Inc., Pierre Fabre Médicament SAS are dominant in this area. They take 17.10% of the total patent filing.
California, United States
Patent: 15
undefined undefined
Patent: 8
Washington, United States
Patent: 7
No data, please try another search term
With the analysis among related 43 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing G2G Bio Co., Ltd., EmboMedics, Inc., HLB Pharmaceutical Co., Ltd. take 39.53% of patent filing during this period.
Minnesota, United States
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
Jiangsu Sheng, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Missouri, United States
Patent: 1
Chongqing Shi, China
Patent: 1
Nanjing Ruilishi Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 43 patents in last 5 years, we discover 11 new entrants. G2G Bio Co., Ltd., EmboMedics, Inc., HLB Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Minnesota, United States
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
Jiangsu Sheng, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Missouri, United States
Patent: 1
Chongqing Shi, China
Patent: 1
Nanjing Ruilishi Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Sichuan Sheng, China
Patent: 1
With the analysis among 44 patents, we discovered top 16 universities and scientific research institutions by total patent application. Universidade Federal de Minas Gerais, Rice University, Rutgers State University of New Jersey are dominant in this area. They take 36.36% of the total patent filing.
Minas Gerais, Brazil
Patent: 6
Texas, United States
Patent: 3
New Mexico, United States
Patent: 2
São Paulo, Brazil
Patent: 2
Minnesota, United States
Patent: 1
Illinois, United States
Patent: 1
Missouri, United States
Patent: 1
Guangdong Sheng, China
Patent: 1
New York, United States
Patent: 1
Shanghai Shi, China
Patent: 1